Screening of feature genes of the ovarian cancer epithelia with DNA microarray

Journal of Ovarian Research

Volumn 6, Issue 1, 2013, Pages

  Ying, Huanchun ^a   Lv, Jing ^b   Ying, Tianshu ^a   Li, Jun ^a   Yang, Qing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Fifth Hospital of Shenyang   (China)

Author keywords

Cell cycle; Cluster analysis; Differentially expressed gene; Module analysis; Ovarian cancer; Pathway analysis

Indexed keywords

DNA; LIPID;

ARTICLE; CELL CYCLE; CLUSTER ANALYSIS; CYTOSKELETON; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC SCREENING; LASER CAPTURE MICRODISSECTION; LIPID METABOLISM; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84878436923     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-6-39     Document Type: Article

References (34)

1. Stem cell-like gene expression in ovarian cancer predicts type ii subtype and prognosis. Schwede M, Spentzos D, Bentink S, Hofmann O, Haibe-Kains B, Harrington D, Quackenbush J, Culhane AC, PLoS One 2013 8 57799 10.1371/journal.pone.0057799 23536770
2. MDR gene expression analysis of six drug-resistant ovarian cancer cell lines. Januchowski R, Wojtowicz K, Sujka-Kordowska P, Andrzejewska M, Zabel M, Biomed Res Int 2013 2013 241763 23484165
3. Ovarian surface epithelium: biology, endocrinology, and pathology. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC, Endocr Rev 2001 22 255 288 10.1210/er.22.2.255 11294827
4. Changes in gene expression and cellular architecture in an ovarian cancer progression model. Creekmore AL, Silkworth WT, Cimini D, Jensen RV, Roberts PC, Schmelz EM, PLoS One 2011 6 17676 10.1371/journal.pone.0017676 21390237
5. Overexpression of the beta subunit of human chorionic gonadotropin promotes the transformation of human ovarian epithelial cells and ovarian tumorigenesis. Guo X, Liu G, Schauer IG, Yang G, Mercado-Uribe I, Yang F, Zhang S, He Y, Liu J, Am J Patho 2011 179 1385 1393 10.1016/j.ajpath.2011.05.018
6. High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. Yoshihara K, Tsunoda T, Shigemizu D, Fujiwara H, Hatae M, Masuzaki H, Katabuchi H, Kawakami Y, Okamoto A, Nogawa T, et al. Clin Cancer Res 2012 18 1374 1385 10.1158/1078-0432.CCR-11-2725 22241791
7. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, et al. J Pathol 2010 221 49 56 10.1002/path.2696 20229506
8. Integrated genomic analyses of ovarian carcinoma. Bell D, Berchuck A, Birrer M, et al. Nature 2011 474 609 615 10.1038/nature10166 21720365
9. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, et al. Clin Cancer Res 2008 14 5198 5208 10.1158/1078-0432.CCR-08-0196 18698038
10. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, McDonald JF, BMC Med Genomics 2009 2 71 10.1186/1755-8794-2-71 20040092
11. Missing value estimation methods for DNA microarrays. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB, Bioinformatics 2001 17 520 525 10.1093/bioinformatics/17.6.520 11395428
12. Evaluating different methods of microarray data normalization. Fujita A, Sato JR, Rodrigues Lde O, Ferreira CE, Sogayar MC, BMC Bioinformatics 2006 7 469 10.1186/1471-2105-7-469 17059609
13. Limma: linear models for microarray data. Smyth GK, Bioinformatics and Computational Biology Solutions using R and Bioconductor New York: Springer, Gentleman VC R, Dudoit S, Irizarry R, Huber W, 2005 397 420
14. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Klipper-Aurbach Y, Wasserman M, Braunspiegel-Weintrob N, Borstein D, Peleg S, Assa S, Karp M, Benjamini Y, Hochberg Y, Laron Z, Med Hypotheses 1995 45 486 490 10.1016/0306-9877(95)90228-7 8748093
15. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Da Huang W, Sherman BT, Lempicki RA, Nucleic Acids Res 2009 37 1 13 10.1093/nar/gkn923 19033363
16. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR, Nat Genet 2002 31 19 20 10.1038/ng0502-19 11984561
17. Functional cartography of complex metabolic networks. Guimera R, Nunes Amaral LA, Nature 2005 433 895 900 10.1038/nature03288 15729348
18. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A, Genome Biol 2007 8 3 10.1186/gb-2007-8-1-r3 17204154
19. Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, Liebow M, Schildkraut J, Berchuck A, Couch FJ, Wang X, et al. Br J Cancer 2009 101 1461 1468 10.1038/sj.bjc.6605284 19738611
20. Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. Ricke RM, Jeganathan KB, Van Deursen JM, J Cell Biol 2011 193 1049 1064 10.1083/jcb.201012035 21646403
21. Cdc20: a potential novel therapeutic target for cancer treatment. Wang Z, Wan L, Zhong J, Inuzuka H, Liu P, Sarkar FH, Wei W, Wang Z, Wan L, Zhong J, Inuzuka H, Liu P, Sarkar FH, Wei W, Curr Pharm Des 2013 19 3210 3214 10.2174/1381612811319180005 23151139
22. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Mondal G, Sengupta S, Panda CK, Gollin SM, Saunders WS, Roychoudhury S, Carcinogenesis 2007 28 81 92 10.1093/carcin/bgl100 16777988
23. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Kim JM, Sohn HY, Yoon SY, Oh JH, Yang JO, Kim JH, Song KS, Rho SM, Yoo HS, Kim YS, et al. Clin Cancer Res 2005 11 473 482 15701830
24. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20. Marucci G, Morandi L, Magrini E, Farnedi A, Franceschi E, Miglio R, Calo D, Pession A, Foschini MP, Eusebi V, Virchows Arch 2008 453 599 609 10.1007/s00428-008-0685-7 18953566
25. Identification of common differentially expressed genes in urinary bladder cancer. Zaravinos A, Lambrou GI, Boulalas I, Delakas D, Spandidos DA, PLoS One 2011 6 18135 10.1371/journal.pone.0018135 21483740
26. Identification and validation of genes involved in cervical tumourigenesis. Rajkumar T, Sabitha K, Vijayalakshmi N, Shirley S, Bose MV, Gopal G, Selvaluxmy G, BMC Cancer 2011 11 80 10.1186/1471-2407-11-80 21338529
27. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Ouellet V, Guyot MC, Le Page C, Filali-Mouhim A, Lussier C, Tonin PN, Provencher DM, Mes-Masson AM, Int J Cancer 2006 119 599 607 10.1002/ijc.21902 16572426
28. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM, Proc Natl Acad Sci U S A 2004 101 9309 9314 10.1073/pnas. 0401994101 15184677
29. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z, Nat Genet 2006 38 1043 1048 10.1038/ng1861 16921376
30. CDC25 phosphatase inhibitors: an update. Lavecchia A, Di Giovanni C, Novellino E, Mini Rev Med Chem 2012 12 62 73 10.2174/138955712798868940 22070688
31. Regulation of cancer cell metabolism. Cairns RA, Harris IS, Mak TW, Nat Rev Cancer 2011 11 85 95 21258394
32. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Menendez JA, Lupu R, Nat Rev Cancer 2007 7 763 777 10.1038/nrc2222 17882277
33. Lipid metabolic pathways as lung cancer therapeutic targets: a computational study. Yano K, Int J Mol Med 2011 29 519 529 22211244
34. Microtubule stabilising agents for cancer chemotherapy. Zhao Y, Fang WS, Pors K, Expert Opin Ther Pat 2009 19 607 622 10.1517/13543770902775713 19441937